Literature DB >> 24603586

Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application.

Mi-Die Xu1, Peng Qi1, Xiang Du2.   

Abstract

Long non-coding RNAs (lncRNAs) are a class of newly identified non-coding RNA molecules that are emerging as key regulators of tumor initiation and development. Colorectal cancer (CRC) remains a major health problem worldwide, and there remains a need to further refine the current screening approaches as well as provide tailored diagnostic and therapeutic approaches. Multiple dysregulated lncRNAs participate in tumorigenesis through a variety of molecular mechanisms, and various regulatory factors frequently contribute to the aberrant expression of lncRNAs in CRC, thereby allowing malignant transformation. Additionally, the association of dysregulated lncRNAs with specific developmental stages and clinical outcomes indicates their potential as strong diagnostic and prognostic predictors as well as therapeutic targets. Here we provide a brief overview of the known functions of CRC-associated lncRNAs, describe some potential molecular mechanisms that underlie changes in lncRNA expression in CRC, and attempt to uncover their clinical and therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603586     DOI: 10.1038/modpathol.2014.33

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  45 in total

Review 1.  Focusing on long noncoding RNA dysregulation in gastric cancer.

Authors:  Lu Gan; Midie Xu; Yi Zhang; Xia Zhang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-12-13

2.  Noncoding RNAs in inflammation and colorectal cancer.

Authors:  Shengyun Ma; Tianyun Long; Wendy Jia Men Huang
Journal:  RNA Biol       Date:  2019-12-26       Impact factor: 4.652

Review 3.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

4.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.

Authors:  Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

5.  Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs.

Authors:  Ahmed A Abd-Rabou; Ahmed M Abdelaziz; Olfat G Shaker; Ghada Ayeldeen
Journal:  Mol Biol Rep       Date:  2021-09-01       Impact factor: 2.316

6.  Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.

Authors:  Gangling Tong; Xuan Wu; Boran Cheng; Liang Li; Xi Li; Zhu Li; Qiaohong Nong; Xiaoqiu Chen; Yajie Liu; Shubin Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 7.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

Authors:  Yoshinaga Okugawa; William M Grady; Ajay Goel
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

8.  The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.

Authors:  Yifan Lian; Jie Ding; Zhihong Zhang; Yongguo Shi; Ya Zhu; Juan Li; Peng Peng; Jirong Wang; Yingrui Fan; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2015-12-17

9.  The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ25-35 Induced Neuronal Injury Through Regulating the Expression of miR-132-3p in Neuronal Cells.

Authors:  Yunli Ge; Xiaolin Song; Jianfeng Liu; Chun Liu; Changshui Xu
Journal:  Neurochem Res       Date:  2020-01-02       Impact factor: 3.996

Review 10.  Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance.

Authors:  Rana Shafabakhsh; Farzaneh Arianfar; Massoud Vosough; Hamid Reza Mirzaei; Maryam Mahjoubin-Tehran; Hashem Khanbabaei; Hamed Kowsari; Layla Shojaie; Maryam Ebadi Fard Azar; Michael R Hamblin; Hamed Mirzaei
Journal:  Cancer Gene Ther       Date:  2021-01-11       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.